MDS Virtual Congress 2021 Archives - Page 102 of 132

Facial dyskinesias mimics a new-onset status epilepticus in a patient with autoimmune encephalitis

J. Diestel Bautista, Z. Rojas Cheje, A. Michel Chavez, C. Mendoza Tejeda, D. Rebolledo García, H. Sentíes Madrid (México City, Mexico)
Facial emotion recognition and social behavioral problems in de novo parkinson’s disease patients

A. Slomp, S. Vander Zee, J. Boertien, M. Gerritsen, T. van Laar, J. Spikman (Groningen, Netherlands)
Facial Paralysis Associated with COVID-19: a systematic review.

B. Franco, G. Aragão, M. Pereira, I. Vasconcelos, A. Nunes, C. Filho (Salvador, Brazil)
Factors contributing to prefrontal cortical activity during walking and its response to dual-tasking in Parkinson’s disease

R. Vitorio, S. Stuart, M. Mancini (Portland, USA)
Falls in Parkinson’s Disease: The Impact of Cognitive Performance

F. Rolim, A. Gomes, V. Santos, D. Torres, F. Carvalho (Fortaleza, Brazil)
Falls in people with typical Parkinson’s disease and the secret of unexpected functional mobility. A protocol for a mixed-method study design.

A. Hanff, C. Mccrum, A. Leist, M. Zeegers, R. Krüger (Strassen, Luxembourg)
Familial Parkinson’s disease (PD) with anticipation phenomenon. Undescribed variant in the LRRK2 gene (c.4001G> A (p.Arg1334Gln))

M. Mata, C. Jimeno (Madrid, Spain)
Fatal Psychosis in a young Girl

D. Joshi, M. Tapadia, K. Bismaya, A. Kumar (Varanasi, India)
Fatigue in patients with progressive supranuclear palsy

JH. Ahn, J. Song, I. Choi, DY. Lee, J. Youn, JW. Cho (Seoul, Republic of Korea)
Fatty acids and Glucocerebrosidase activity as potential biomarkers of stearyl-CoA desaturase inhibition; an observational study of inter and intraday variation in healthy volunteers and patients with Parkinson’s disease

P. Eijsvogel, A. Gorbenko, D. Tardiff, M. Skupien, M. de Kam, P. Kremer, E. van Brummelen, B. Robertson, GJ. Groeneveld (Leiden, Netherlands)
FEASIBILITY OF A SMARTPHONE-BASED APPROACH TO ACCESS GAIT PARAMETERS AND DETECT FALL RISK IN PARKINSON’S DISEASE

F. Rolim, A. Gomes, E. Barreto, A. Marinho, F. Carvalho (Fortaleza, Brazil)
Feasibility of dance therapy through synchrony videoconference in Parkinson’s disease and elderly people.

C. Pinto, C. Figueiredo, V. Mabilia, I. Cortez, F. Pereira, T. Rosa, I. Bevilacqua, E. Jeffrey, A. Pagnussat (Porto Alegre, Brazil)
Feasibility of Instituting Graduated High intensity Training (FIGHT-PD); Protocol for a non-contact boxing exercise study

D. Blacker, R. Fazio, C. Tucak, M. Turner, S. Rajandran, T. Cruickshank (Nedlands, Australia)
FEASIBILITY OF THE HOME-BASED DANCE EXERCISE FOR ADULTS WITH MODERATE PARKINSON’S DISEASE – A PILOT STUDY CASE REPORT

M. Ferreira, A. da Silva, B. Yamaguchi, S. Mathur, V. Israel (Toronto, Canada)
Feasibility study of diffusion tensor imaging fiber tracking in PD patients after DBS operation

Y. Li, C. Zhang, N. He, F. Yan, E. Haacke (Shanghai, China)
Feasibility to Detect Parkinson’s Motor Symptoms with a Waist-Worn Parkinson’s Holter

DRM. Rodriguez-Martin, CPL. Perez-Lopez, MP. Pié, JC. Calvet, ACM. Català, JCM. Cabestany, NC. Caballol, AB. Bayés (Cornellà de Llobregat, Spain)
Fecal Calprotectin in Parkinson’s Disease and Multiple System Atrophy

JW. Hor, ES. Khor, KK. Chong, SL. Song, CW. Chong, SY. Lim, AH. Tan (Kuala Lumpur, Malaysia)
FINANCIAL COST OF PARKINSON’S DISEASE IN BRAZIL IN THE LAST 10 YEARS

R. Oliveira, S. Moura, L. Cruz, N. Cruz (Salvador, Brazil)
Findings from a Community-based LOUD Crowd® Program for People with Parkinson Disease

S. Parveen, A. Mandaville (Stillwater, USA)
Fine-grained prediction of Huntington’s disease stage using a meta-model approach

M. Kohli, S. Gregory, R. Scahill, S. Tabrizi, D. Alexander, P. Wijeratne (London, United Kingdom)
First in history MRgFUS treatment procedures remote start and successful treatment of PD patients due to COVID-19 epidemic

R. Galimova, O. Kachemaeva, G. Akhmadeeva, YU. Sidorova, D. Krekotin, I. Buzaev (Ufa, Russian Federation)
FIRST-IN-MAN CLINICAL TRIAL OF INTRAPUTAMENAL CDNF IN PARKINSON’S DISEASE FINDS A CONSORTED BIOMARKER RESPONSE IN A SUBGROUP OF SUBJECTS

H. Huttunen, S. Booms, M. Sjögren, A. Cryar, J. Harris, E. Sirka, M. Dove, N. Majbour, H. Abdesselem, O. El-Agnaf, J. Koskinen, R. Holmnäs, V. Kerstens, J. Johansson, J. Rinne, A. Varrone, M. Woolley, B. Murphy, P. Fielder, J. Baker, P. Skinner, M. Andreasson, G. Paul-Visse, R. Kivisaari, H. Bjartmarz, G. Lind, P. Almqvist, F. Scheperjans, H. Widner, P. Svenningsson (Espoo, Finland)
FOG-IT – Towards Personalized Freezing of Gait detection using Artificial Intelligence

B. Filtjens, N. Ghosh, P. Slaets, B. Vanrumste, A. Nieuwboer, P. Ginis (Leuven, Belgium)
Founder effect in (TTTTA)exp(TTTCA)exp and pure (TTTTA)exp in familial cortical myoclonic tremor with epilepsy type 1-SAMD12 locus

ZD. Cen, XH. Chen, HT. Wang, DH. Yang, F. Zhang, Y. Chen, S. Chen, LB. Wang, P. Liu, F. Xie, B. Wang (Hangzhou, China)
Fragile X-Associated Tremor Ataxia Syndrome Rating Scale (FXTAS-RS): development process using the Delphi method

M. Tosin, G. Stebbins, C. Goetz, R. Hagerman, D. Hessl, M. Zolecki, P. Todd, M. Leehey, D. Hall (Chicago, USA)
FREEZESTEP = DALFLEX

D. Dalal, A. Mehta, P. R, M. Javali, P. Acharya (Bengaluru, India)
Freezing of gait in Parkinson’s disease: A 4-item FOG-Quick questionnaire assessment

W. Phuenpathom, O. Phokaewvarangkul, R. Bhidayasiri (Bangkok, Thailand)
Frequency and outcome of intraoperative lead adjustment in awake deep brain stimulation surgery in Parkinson’s disease

D. Basson, R. van Coller, C. Schutte, P. Slabbert, J. Wuzyk (Pretoria, South Africa)
Functional connectivity as an early marker of indication for deep brain stimulation treatment in Parkinson’s disease (PD)

L. Albano, F. Agosta, S. Basaia, C. Cividini, T. Stojkovic, E. Sarasso, I. Stankovic, A. Tomic, V. Markovic, E. Stefanova, P. Mortini, V. Kostic, M. Filippi (Milan, Italy)
Functional connectivity predictive of efficacy for thalamic deep brain stimulation for Tourette Syndrome

JC. Baldermann, C. Hennen, V. Visser-Vandewalle, D. Huys, M. Barbe (Cologne, Germany)
Functional Constipation in Parkinson’s Disease

S. Pavan, M. Ballal, A. Prabhu, S. Gorthi, B. Das, A. Mutreja, T. Ramamurthy, A. Pai (Manipal, India)
Functional Movement Disorder in a Nine-Year-Old Girl

J. Brasic (Baltimore, USA)
Functional neurological symptoms as initial presentation of Creutzfeldt-Jacob Disease: case series.

V. Gómez-Mayordomo, M. Kojovic, E. López-Valdés, F. Alonso-Frech, A. Horga-Hernández, R. Fernández-Rodríguez, I. Pareés (Madrid, Spain)
Functional Outcomes Following a Group Exercise and Education Program in Patients with Parkinson’s Disease

S. Schwartz, M. Twomey, A. Grover, T. Clifford, S. O'Sullivan (Cork, Ireland)